Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 271-280 of 307 for infectious diseases

Edit search filters
  1. A Study to Evaluate the Performance of Chembio Diagnostics Systems, Inc. DPP® Zika IgM Assay System With Fingerstick Whole Blood (MVSS CBD002-18 PRO)

    Rochester, MN

  2. Characterizing HIV-related Diastolic Dysfunction

    Rochester, MN

  3. Impact of Rapid Detection of MRSA

    Rochester, MN

  4. A Study of the Quantiferon CMV Blood Test to Predict the Risk of CMV Returning After Treatment of the Disease in Solid Organ Transplant Recipients

    Rochester, MN

  5. A Study to Evaluate Clinical Performance of the Aptima® CMV Quant Assay on the Panther® System

    Rochester, MN

  6. Outcomes following treatment of the infected Achilles tendon

    Rochester, MN

  7. A Study to Assess Monoclonal B-cell Lymphocytosis in Individuals with Chronic Hepatitis C

    Rochester, MN

  8. Immune Cell Activation of Healthy Human Subjects

    Rochester, MN

  9. A Study Of The Characteristics And Outcomes Of Treatment For C. Diff In Post-Transplant Patients

    Rochester, MN

  10. Laboratory Assay Optimization 2.0

    Rochester, MN

.

Mayo Clinic Footer